HEXO Corp. HEXO NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

19/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HEXO Corp. (HEXO) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 18/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

17/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

8/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — HEXO

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.10

EV/EBITDA0.0

每股数据

EPS (TTM)$-38.68

每股账面价值$0.00

每股营收$6.88

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$0.00	$0.00	$-29.29K	-
2015	$-0.92	$0.00	$-29.29K	-
2016	$0.00	$0.00	$0.00	-
2017	$-11.88	$4.1M	$-12.42M	-303.1%
2018	$-9.75	$4.93M	$-23.35M	-473.2%
2019	$-21.47	$47.54M	$-81.56M	-171.6%
2020	$-63.43	$80.78M	$-546.49M	-676.5%
2021	$-12.62	$123.77M	$-114.76M	-92.7%
2022	$-38.68	$191.1M	$-1.07B	-561.8%